Reasonable Growth, Debt Levels, and a High ROIC Make IRADIMED CORP (NASDAQ:IRMD) Appealing to Quality Investors.

In this article we will dive into IRADIMED CORP (NASDAQ:IRMD) as a possible candidate for quality investing. Investors should always do their own research, but we noticed IRADIMED CORP showing up in our Caviar Cruise quality screen, which makes it worth to investigate a bit more.

A Deep Dive into IRADIMED CORP's Quality Metrics.

• IRADIMED CORP has demonstrated significant revenue growth over the past 5 years, with a 16.58% increase. This underscores the company's ability to adapt to market dynamics and capitalize on growth opportunities.
• The ROIC excluding cash and goodwill of IRADIMED CORP stands at 53.49%, reflecting the company's strong financial management and profitability. This metric underscores its ability to generate favorable returns on the capital invested in its core operations.
• The Debt/Free Cash Flow Ratio of IRADIMED CORP stands at 0.0, reflecting the company's prudent capital structure and cash flow dynamics. This ratio highlights the company's ability to generate robust free cash flow relative to its debt obligations.
• The Profit Quality (5-year) of IRADIMED CORP stands at 137.0%, highlighting its ability to consistently generate reliable profits. This metric underscores the company's strong business fundamentals and reinforces its position as a financially stable entity.
• The 5-year EBIT growth of IRADIMED CORP has been remarkable, with 27.27% increase. This demonstrates the company's ability to improve its operational efficiency and indicates its competitiveness within the market.
• IRADIMED CORP has achieved impressive EBIT 5-year growth, surpassing its Revenue 5-year growth. This indicates the company's ability to improve its profitability and operational efficiency, highlighting its strong financial performance.

How does the complete fundamental picture look for NASDAQ:IRMD?

ChartMill assigns a Fundamental Rating to every stock. This score, ranging from 0 to 10, is updated daily and is determined by evaluating multiple fundamental indicators and properties.

Taking everything into account, IRMD scores 7 out of 10 in our fundamental rating. IRMD was compared to 191 industry peers in the Health Care Equipment & Supplies industry. IRMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IRMD is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make IRMD a good candidate for growth and quality investing.

Our latest full fundamental report of IRMD contains the most current fundamental analsysis.

More ideas for quality investing can be found on ChartMill in our Caviar Cruise screen.

Disclaimer

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.